The first phase of a $300 million expansion at Indianapolis-based Roche Diagnostics Corp. is now complete. Hear from the Roche Group chairman, in town from Switzerland, on what he thinks about Indiana.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}